Searchable abstracts of presentations at key conferences in endocrinology

ea0078p21 | Diabetes | BSPED2021

A single-centre evaluation of telemedicine consultation and associated CO2 emissions for children and young people with diabetes

Andrews Edward , Catton Tim , Odeleye Esther , Kumaran Anitha , Trevelyan Nicola

Background: Telemedicine use has increased rapidly during the COVID-19 pandemic, replacing many face-to-face (FTF) consultations. FTF consultations are associated with increased CO2 emissions (CO2em) from travel to clinics. This study evaluates the triple bottom line of children and young people’s (CYP) and parent or guardian experience of a new telemedicine service, estimated CO2em saving from reduced travel and cost saving to families.Methods: Dat...

ea0051p010 | Adrenal | BSPED2017

An unusual presentation of congenital lipoid adrenal hyperplasia and novel STAR mutation in two siblings

Andrews Edward , Taylor Carl , Metherell Lou , Buonocore Frederica , Achermann John , Maharaj Avinaash , Davies Justin H

Introduction: Congenital lipoid adrenal hyperplasia (CLAH) is rare and caused by mutations in the steroidogenic acute regulatory (STAR) gene, which is involved in a key step in the synthesis of pregnenolone from cholesterol. Cases typically present in the first days of life with severe adrenal crisis, salt wasting and severely disrupted androgen secretion which may result in sex reversal in 46, XY individuals.Case report: We present a 21-month-o...

ea0051p056 | Pituitary and growth | BSPED2017

Embedding electronic growth charts into clinical practice at a children’s hospital

Andrews Edward , Wootton Stephen , Cable David , Marchant Alastair , Miller Harriet , Davies Justin

Background: Accurate evaluation of growth is a key assessment of child health, in the UK use of a paper growth chart is currently standard practice. Our trust had a drive to become paper light thus there needed to be a way to store growth data electronically. Growth data is often incompletely documented. A previous review of children’s outpatient attendances at our hospital found that across medical, surgical and tertiary specialties only 33% of children had growth data d...

ea0095p107 | Diabetes 3 | BSPED2023

Levelling the Levemir: Are we prescribing too much long-acting insulin to children at diagnosis?

Gann Henry , Clarke Joely , Mitropoulou Eirini , Deamer Susannah , Andrews Edward , Knight Emma

Introduction: National guidance from the Association of Children’s Diabetes Clinicians (ACDC) recommends starting children with newly diagnosed type 1 diabetes mellitus on a total daily insulin dose of 0.5–0.75 iU per kilo per day (kg/d). This equates to a basal insulin dose of between 0.25–0.375 iU/kg per day. Local practice suggested many patients required a significantly smaller starting dose of basal insulin.Ai...